These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 10371033)

  • 21. A combinatorial method to isolate short ribozymes from complex ribozyme libraries.
    Arriola JT; Müller UF
    Nucleic Acids Res; 2020 Nov; 48(20):e116. PubMed ID: 33035338
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleic acid enzymes.
    Carola C; Eckstein F
    Curr Opin Chem Biol; 1999 Jun; 3(3):274-83. PubMed ID: 10359709
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cross-ligation and exchange reaction of RNA catalyzed by hairpin ribozymes.
    Komatsu Y; Koizumi M; Sekiguchi A; Ohtsuka E
    Nucleic Acids Symp Ser; 1992; (27):43-4. PubMed ID: 1283911
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modern mode of activation for nucleic acid enzymes.
    Lévesque D; Brière FP; Perreault JP
    PLoS One; 2007 Jul; 2(7):e673. PubMed ID: 17653287
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Catalytic strategies of self-cleaving ribozymes.
    Cochrane JC; Strobel SA
    Acc Chem Res; 2008 Aug; 41(8):1027-35. PubMed ID: 18652494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Activities of HIV-RNA targeted ribozymes transcribed from a 'shot-gun' type ribozyme-trimming plasmid.
    Ohkawa J; Yuyama N; Taira K
    Nucleic Acids Symp Ser; 1992; (27):15-6. PubMed ID: 1289797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Examination of the catalytic fitness of the hammerhead ribozyme by in vitro selection.
    Tang J; Breaker RR
    RNA; 1997 Aug; 3(8):914-25. PubMed ID: 9257650
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ribozyme structures and mechanisms.
    Doherty EA; Doudna JA
    Annu Rev Biochem; 2000; 69():597-615. PubMed ID: 10966470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Group I Intron-Based Therapeutics Through Trans-Splicing Reaction.
    Lee CH; Han SR; Lee SW
    Prog Mol Biol Transl Sci; 2018; 159():79-100. PubMed ID: 30340790
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced folding of hairpin ribozymes with replaced domains.
    Komatsu Y; Kanzaki I; Ohtsuka E
    Biochemistry; 1996 Jul; 35(30):9815-20. PubMed ID: 8703955
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ribozymes as therapeutic tools for genetic disease.
    Phylactou LA; Kilpatrick MW; Wood MJ
    Hum Mol Genet; 1998; 7(10):1649-53. PubMed ID: 9735387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Group I intron ribozymes.
    Nielsen H
    Methods Mol Biol; 2012; 848():73-89. PubMed ID: 22315064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of a ribozyme-expression system that effectively transports ribozymes to the cytoplasm.
    Sano M; Kuwabara T; Nara Y; Warashina M; Taira K
    Nucleic Acids Symp Ser; 2000; (44):203-4. PubMed ID: 12903339
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cis and trans reactions of hairpin ribozymes derived from the negative strand of arabis mosaic virus satellite RNA.
    Tomita R; Morikawa Y; Hisamatsu S; Suzuki-Fujita K; Tanaka T; Sonoki S; Kikuchi Y
    Nucleic Acids Symp Ser; 1995; (34):117-8. PubMed ID: 8841580
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allosteric selection of ribozymes that respond to the second messengers cGMP and cAMP.
    Koizumi M; Soukup GA; Kerr JN; Breaker RR
    Nat Struct Biol; 1999 Nov; 6(11):1062-71. PubMed ID: 10542100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selecting allosteric ribozymes.
    Piganeau N
    Methods Mol Biol; 2012; 848():317-28. PubMed ID: 22315077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ribozyme: a clinical tool.
    Khan AU
    Clin Chim Acta; 2006 May; 367(1-2):20-7. PubMed ID: 16426595
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A cis and trans adenine-dependent hairpin ribozyme against Tpl-2 target.
    Li YL; Torchet C; Vergne J; Maurel MC
    Biochimie; 2007 Oct; 89(10):1257-63. PubMed ID: 17703868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Group II intron ribozymes that cleave DNA and RNA linkages with similar efficiency, and lack contacts with substrate 2'-hydroxyl groups.
    Griffin EA; Qin Z; Michels WJ; Pyle AM
    Chem Biol; 1995 Nov; 2(11):761-70. PubMed ID: 9383483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Catalytic strategies of the hepatitis delta virus ribozymes.
    Shih IH; Been MD
    Annu Rev Biochem; 2002; 71():887-917. PubMed ID: 12045114
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.